International Journal of Nephrology / 2016 / Article / Tab 3

Research Article

Serum Endocan Levels Associated with Hypertension and Loss of Renal Function in Pediatric Patients after Two Years from Renal Transplant

Table 3

Logistic regression analysis for the presence of hypertension and chronic kidney disease (CKD) in RT children.

Variables Univariate
Analysis Analysis
OR (95% CI) valueOR (95% CI) value

Age (per years)1.110 (0.884–1.395)0.369
Male gender (no/yes)1.333 (0.269–5.606)0.725
BMI (per Kg/m2)1.066 (0.902–1.260)0.456
Pulse pressure (mmHg)1.084 (1.015–1.157)0.0161.079 (0.969–1.202)0.166
Endocan (per ng/mL)1.855 (1.187–2.898)0.0072.070 (1.097–3.907)0.035
Donor age (per year)0.832 (0.708–0.978)0.0860.839 (0.659–1.085)0.317
Male donor (no/yes)1.367 (0.860–1.767)0.1761.317 (0.448–4.577)0.399
Preexisting hypertension (no/yes)4.437 (0.449–9.723)0.224
Chronic dialysis (per months)1.021 (0.932–1.120)0.652
Delayed graft function (no/yes)1.592 (0.382–6.625)0.523
Cold ischemia time (per min)1.048 (0.258–4.256)0.948
Prednisone (no/yes)1.640 (0.168–2.436)0.1981.486 (0.743–5.987)0.567
Tacrolimus (no/yes)2.213 (0.467–7.238)0.298
Mycophenolate mofetil (no/yes)1.201 (0.221–5.521)0.833
Azathioprine (no/yes)0.400 (0.109–1.254)0.251

Data are reported as odds ratio (OR) and 95% confidence interval (95% CI).

Article of the Year Award: Outstanding research contributions of 2020, as selected by our Chief Editors. Read the winning articles.